Skip to content

Study of the Impact of Hypersplenism and Splenectomy on Hepatocarcinogenesis in Patients With Posthepatitic Cirrhosis

Multicentric Retrospective Case Control Study of the Impact of Hypersplenism and Splenectomy on Hepatocarcinogenesis in Patients With Posthepatitic Cirrhosis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01201655
Enrollment
5000
Registered
2010-09-14
Start date
2010-01-31
Completion date
2012-12-31
Last updated
2010-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carcinoma, Hepatocellular, Laparotomy, Liver Cirrhosis, Splenomegaly

Keywords

Posthepatitic cirrhosis;, Hepatocarcinogenesis;, Splenectomy;

Brief summary

The purpose of this study is to investigate the impact of splenectomy coupled with portal-azygous disconnection on hepatocarcinogenesis in patients with post-hepatitic cirrhosis after hepatitis B or C virus infection by retrospective case-control study,We hope to find a new idear and method to prevent or cure HCC.

Detailed description

A case-control study was carried out. The factors studied include age, gender, ascites, hepatic encephalopathy, ALT, AST, TBIL, ALP, GGT, Child-Pugh classification of liver function, and history of splenectomy with portal-azygous disconnection during the treatment of portal hypertension. According to the Child-Pugh classification, these cases were graded as A, B, and C. And according to the ranges of the normal reference values of the data, they were categorized into two groups including a normal group and an abnormal group.The data mainly comes from FMMU and Xi'an jiaotong university from the year of 2002 to 2012.

Interventions

None listed

Sponsors

Air Force Military Medical University, China
CollaboratorOTHER
Xi'an Jiaotong University
CollaboratorOTHER
Xijing Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* after surgery

Exclusion criteria

* without surgery

Countries

China

Contacts

Primary ContactChen yong, professor
cheny@fmmu.edu.cn13891915509

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026